Latest updates for Boehringer Ingelheim

Fresh curated links around Boehringer Ingelheim are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • <![CDATA[Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal]]>
  • Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset
  • Boehringer Wants Generic For Blockbuster Jardiance Blocked

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

pharmexec.com /2 weeks ago

&lt;![CDATA[Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal]]&gt;

Read source
fiercebiotech.com /2 weeks ago

Boehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset

Boehringer Ingelheim has put up 407.5 million euros in biobucks to secure global rights to a first‑in‑class antibody Immunitas Therapeutics is developing for chronic inflammatory a...

Read source
law360.com /1 month ago

Boehringer Wants Generic For Blockbuster Jardiance Blocked

Boehringer Ingelheim has hit an Arizona business with a patent lawsuit in Delaware federal court seeking to stop it from moving forward with a generic version of its diabetes drug...

Read source
pharmexec.com /1 week ago

&lt;![CDATA[Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio]]&gt;

Read source
fiercebiotech.com /1 month ago

Boehringer, Amgen discard early immunology candidates over lack of clinical potential

Boehringer Ingelheim and Amgen have both canned early-stage immunology candidates after the prospects showed little clinical promise.

Read source
fiercebiotech.com /1 month ago

Boehringer hands over funding, marketing rights for Click’s digital therapeutic

Boehringer Ingelheim and Click Therapeutics are restructuring their marketing deal for the software-based schizophrenia treatment CT-155, as the German pharma also opens its coffer...

Read source
pharmexec.com /1 week ago

&lt;![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]&gt;

Read source
pharmexec.com /1 week ago

&lt;![CDATA[Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand St...

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Pharma M&amp;A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-P...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals ]]&gt;

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[FDA Extends Priority Review of Leqembi Iqlik Subcutaneous Injection ]]&gt;

Read source
cafepharma.com /5 days ago

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

Read source
cafepharma.com /1 month ago

Beigene

Beigene Anonymous (not verified) Thu, 04/30/2026 - 14:18 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics ]]&gt;

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]&gt;

Read source
pharmexec.com /4 days ago

&lt;![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]&gt;

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[Bristol Myers Squibb, Hengrui Pharma Form $15.2 Billion Strategic Drug Development Collaboration]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Gilead Enters $5 Billion Agreement to Acquire Tubulis ]]&gt;

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[FDA Approves Bizengri for Adults with NRG1 Fusion-Positive Cholangiocarcinoma]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]&gt;

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[Model Examples]]&gt;

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Boehringer Ingelheim

cafepharma.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

law360.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source

Related searches